Nadiye Akdeniz

ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 9

Top Venues

Pancreas

International journal of colorectal disease

Future oncology (London, England)

Expert review of molecular diagnostics

This page only lists publications with an associated author ORCID identifier.

Publications

Nadiye Akdeniz, Muhammet Ali Kaplan, Mevlüde İnanç, Doğan Uncu, Yakup Ergün, Mehmet Küçüköner, Ayşe Demirci, Mehmet Ali Nahit Şendur, Mehmet Beşiroğlu, Atakan Topçu, Halis Yerlikaya, Zuhat Urakçi, Saadettin Kiliçkap, Abdurrahman Işikdoğan
The Efficacy and Safety of Treatment Regimens Used in the First-Line Setting in Metastatic Pancreatic Cancer Patients: A Multicenter Real-Life Study. Pancreas 51 (9) (2023)
Nadiye Akdeniz, Muhammet Ali Kaplan, Mevlüde İnanç, Doğan Uncu, Yakup Ergün, Mehmet Küçüköner, Ayşe Demirci, Mehmet Ali Nahit Şendur, Mehmet Beşiroğlu, Atakan Topçu, Halis Yerlikaya, Zuhat Urakçi, Saadettin Kiliçkap, Abdurrahman Işikdoğan
The Efficacy and Safety of Treatment Regimens Used in the First-Line Setting in Metastatic Pancreatic Cancer Patients: A Multicenter Real-Life Study. Pancreas 51 (9) (2023)
Nadiye Akdeniz, Muhammet Ali Kaplan, Mevlüde İnanç, Doğan Uncu, Yakup Ergün, Mehmet Küçüköner, Ayşe Demirci, Mehmet Ali Nahit Şendur, Mehmet Beşiroğlu, Atakan Topçu, Halis Yerlikaya, Zuhat Urakçi, Saadettin Kiliçkap, Abdurrahman Işikdoğan
The Efficacy and Safety of Treatment Regimens Used in the First-Line Setting in Metastatic Pancreatic Cancer Patients: A Multicenter Real-Life Study. Pancreas 51 (9) (2023)
Nadiye Akdeniz, Muhammet Ali Kaplan, Mevlüde İnanç, Doğan Uncu, Yakup Ergün, Mehmet Küçüköner, Ayşe Demirci, Mehmet Ali Nahit Şendur, Mehmet Beşiroğlu, Atakan Topçu, Halis Yerlikaya, Zuhat Urakçi, Saadettin Kiliçkap, Abdurrahman Işikdoğan
The Efficacy and Safety of Treatment Regimens Used in the First-Line Setting in Metastatic Pancreatic Cancer Patients: A Multicenter Real-Life Study. Pancreas 51 (9) (2023)
Mutlu Hizal, Burak Bilgin, Nail Paksoy, Saadettin Kılıçkap, Muhammed Mustafa Atcı, Seda Kahraman, Merve Keskinkılıç, İrem Bilgetekin, Murat Ayhan, Deniz Tural, Önder Eren, Fatma Nihan Akkoç Mustafayev, Şebnem Yaman, Ali Murat Tatlı, Ertuğrul Bayram, Yasin Kutlu, İsmail Ertürk, Erkan Özcan, Ahmet Gülmez, Mustafa Korkmaz, Baran Akagündüz, Dilek Erdem, Tuğba Akın Telli, Asude Aksoy, Necdet Üskent, Yakup İriağaç, Naziyet Köse Baytemür, Dinçer Aydın, Teoman Şakalar, Hacı Arak, Fatih Selçukbiricik, Yakup Ergün, Taner Korkmaz, Naziye Ak, Çağlar Ünal, Nadiye Akdeniz, Mehmet Alpaslan Özgün, Berna Öksüzoğlu, Bülent Yalçın, İlhan Öztop, Efnan Algın, Abdullah Sakin, Adnan Aydıner, Perran Fulden Yumuk, Mehmet Ali Nahit Şendur
Real-world data on efficacy and safety of first-line alectinib treatment in advanced-stage, ALK-positive non-small-cell lung cancer patients: a Turkish Oncology Group study. Future oncology (London, England) 18 (23) (2022)
Nadiye Akdeniz, Muhammet Ali Kaplan, Mehmet Küçüköner, Zuhat Urakçı, Şahin Laçin, Emre Hüsnü Ceylan, Abdurrahman Işıkdoğan
The effect of exercise on disease-free survival and overall survival in patients with breast cancer. Irish journal of medical science (2021)
Nadiye Akdeniz, Muhammet Ali Kaplan, Doğan Uncu, Mevlüde İnanç, Serap Kaya, Faysal Dane, Mehmet Küçüköner, Ayşe Demirci, Mehmet Bilici, Ayşe Gök Durnalı, Lokman Koral, Mehmet Ali Nahit Şendur, Cihan Erol, Esma Türkmen, Ömer Fatih Ölmez, Özgür Açıkgöz, Şahin Laçin, Hayriye Şahinli, Zuhat Urakçı, Abdurrahman Işıkdoğan
The comparison of FOLFOX regimens with different doses of 5-FU for the adjuvant treatment of colorectal cancer: a multicenter study. International journal of colorectal disease 36 (6) (2021)
Nadiye Akdeniz, Mehmet Küçüköner, Muhammet Ali Kaplan, Zuhat Urakçı, Oğur Karhan, Yasin Sezgin, Erkan Bilen, Senar Ebinç, Fatma Teke, Şahin Laçin, Özkan Alan, Özlem Ercelep, Abdurrahman Işıkdoğan, Perran Fulden Yumuk
Comparison of three different chemotherapy regimens for concomitant chemoradiotherapy in locally advanced non-small cell lung cancer. International journal of clinical oncology 25 (12) (2020)
Yakup Ergün, Yusuf Acikgoz, Öznur Bal, Gokhan Ucar, Merve Dirikoc, Eda Caliskan Yildirim, Nadiye Akdeniz, Doğan Uncu
KRAS codon 12 and 13 mutations may guide the selection of irinotecan or oxaliplatin in first-line treatment of metastatic colorectal cancer. Expert review of molecular diagnostics 19 (12) (2019)

Nadiye Akdeniz.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Nadiye Akdeniz